We believe there are no limits to our thinking or what that thinking can accomplish.
Advances in the development of biocompatible fluorescent tracer agents that can be detected by a sensor placed on the skin are at the core of MediBeacon’s scalable medical technology platform. The solutions are being designed to be clinically practical, relevant and easily understood.
Real-time GFR measurement has the potential, if used effectively, to give doctors information that could help them fundamentally transform their understanding of kidney function in such a way that it could change the practice of nephrology, critical care medicine and beyond.
Transdermal GI permeability measurement has the potential to be a tool that could help doctors to evolve their understanding of mucosal healing in a way that can impact the proactive care of those with inflammatory bowel diseases and a range of other autoimmune disorders.
Improvements in ocular and surgical visualization are other possible future uses of the florescent tracer technology.
Our preclinical product enables researchers to measure renal function in a streamlined and accurate manner. Over 400 peer-reviewed and conference abstracts describe the ground breaking research in which the transdermal measured GFR technique has been used. Improvements in preclinical research techniques have the potential to reduce the time it takes to get lifesaving treatments and pharmaceuticals from ideation to commercialization.*
Forward-Looking Statements
Statements on this website may include forward-looking statements within the meaning of certain securities laws, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended.
Forward-Looking Statements
Statements on this website may include forward-looking statements within the meaning of certain securities laws, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended.
These forward-looking statements include, among others, statements with respect to our objectives, goals and strategies to achieve those objectives and goals, as well as statements with respect to our beliefs, plans, objectives, expectations, anticipations, estimates and intentions. The words “may,” “will,” “could,” “should,” “would,” “suspect,” “outlook,” “believe,” “plan,” “anticipate,” “estimate,” “expect,” “intend,” “forecast,” “objective,” “hope,” and “continue” (or the negative thereof), and words and expressions of similar import, are intended to identify forward-looking statements.
By their very nature, forward-looking statements involve inherent risks and uncertainties, both general and specific, which give rise to the possibility that predictions, forecasts, projections and other forward-looking statements will not be achieved. Certain material factors or assumptions are applied in making forward-looking statements and actual results may differ materially from those expressed or implied in such statements. We caution readers not to place undue reliance on these statements as a number of important factors, many of which are beyond our control, could cause our actual results to differ materially from the beliefs, plans, objectives, expectations, anticipations, estimates and intentions expressed in such forward-looking statements. These factors include, but are not limited to; the applicability of patents and proprietary technology; possible patent litigation; approval of products in the company’s pipeline; marketing of products; meeting projected development timelines and goals; product liability and insurance; dependence on strategic partnerships and licenses; concentration of the company’s revenue; substantial competition and rapid technological change in the industry; the publication of negative results of clinical trials of the company’s products; the ability to access capital; the ability to attract and retain key personnel; changes in government regulation or regulatory approval processes; dependence on contract research organizations; third party reimbursement; the success of the company’s strategic investments; the achievement of development goals and time frames; the possibility of shareholder dilution; market price volatility of securities; and the existence of significant shareholders.
We caution that the foregoing list of important factors that may affect future results is not exhaustive. When reviewing our forward-looking statements, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. The information contained on this website is intended to be reviewed in its totality, and any stipulations, conditions or provisos that apply to a given piece of information in one part of this website should be read as applying to every other instance of such information appearing herein.
We do not undertake to update any forward-looking statements, whether written or oral, that may be made from time to time by us or on our behalf; such statements speak only as of the date made. The forward-looking statements included herein are expressly qualified in their entirety by this cautionary language.